Showing results (141-150 of 260) with videos related to
Sort By:
Pageof 26
Experimental Dermatology|July 1, 2024
Reactivity against the BP180 ectodomain in patients with bullous pemphigoid, mucous membrane pemphigoid, multiple sclerosis and Parkinson diseaseJonathan Tegtmeyer, Maurizio Romagnuolo, Christoph M Hammers, et al.JAMA Dermatology|January 11, 2023
Characteristics Associated With Refractory Course, Blindness, and Treatment Strategy-Related Outcomes in Patients With Mucous Membrane PemphigoidKhalaf Kridin, Nina van Beek, Elena Bühler, et al.The Journal of Investigative Dermatology|January 15, 2016
Epidermolysis Bullosa Acquisita: From Pathophysiology to Novel Therapeutic OptionsMichael Kasperkiewicz, Christian D Sadik, Katja Bieber, et al.Orphanet Journal of Rare Diseases|December 11, 2014
Bullous pemphigoid in infants: characteristics, diagnosis and treatmentAgnes Schwieger-Briel, Cornelia Moellmann, Birgit Mattulat, et al.Emerging Infectious Diseases|May 12, 2020
SARS-CoV-2 Transmission from Presymptomatic Meeting Attendee, GermanyDirkJan Hijnen, Angelo Valerio Marzano, Kilian Eyerich, et al.Journal of the American Academy of Dermatology|January 16, 2021
Immunoglobulin M pemphigoidKatharina Boch, Christoph M Hammers, Stephanie Goletz, et al.Experimental Dermatology|August 26, 2009
Animal models for autoimmune bullous dermatosesKatja Bieber, Shijie Sun, Norito Ishii, et al.The Journal of Clinical Investigation|January 10, 2013
Peptide-mediated desmoglein 3 crosslinking prevents pemphigus vulgaris autoantibody-induced skin blisteringVolker Spindler, Vera Rötzer, Carina Dehner, et al.Plos One|August 23, 2012
Pathogenicity of autoantibodies in anti-p200 pemphigoidKaterina Vafia, Stephanie Groth, Tina Beckmann, et al.JAMA Dermatology|November 24, 2021
Evaluation of Site- and Autoantigen-Specific Characteristics of Mucous Membrane PemphigoidNina van Beek, Khalaf Kridin, Elena Bühler, et al.Pageof 26